Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
CLOV Stock Alert: What to Know About Clover Health's Big Insider Buy
11:02am, Wednesday, 14'th Aug 2024
Clover Health (NASDAQ: CLOV ) co-founder and Executive Chairman Vivek Garipalli bought 531,700 shares of his troubled health insurance company this month. The executive now owns over 1.4 million share
Clover Health Investments, Corp. (CLOV) Hit a 52 Week High, Can the Run Continue?
10:16am, Wednesday, 14'th Aug 2024
Clover Health Investments (CLOV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Clover Health Investments (CLOV) Is Attractively Priced Despite Fast-paced Momentum
09:50am, Thursday, 08'th Aug 2024
Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently bu
3 Healthcare AI Stocks Positioned for Potential Breakthroughs
06:47am, Wednesday, 07'th Aug 2024
Markets tanked on Monday because the Japanese central bank raised its interest rate to 0.25%. Interest rates were originally at a benchmark between 0 and 0.1, meaning a minor 15- to 25-basis-point inc
Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript
07:35pm, Monday, 05'th Aug 2024
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Peter Kuipers - CFO Conference Call P
Clover Health Investments, Corp. (CLOV) Q2 Earnings and Revenues Beat Estimates
07:10pm, Monday, 05'th Aug 2024
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.06 per share
Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance
04:05pm, Monday, 05'th Aug 2024
Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP l
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
04:05pm, Wednesday, 24'th Jul 2024
FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company c
Clover Health to Report Second Quarter 2024 Financial Results on August 5
04:05pm, Monday, 22'nd Jul 2024
FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to grea
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
04:15pm, Wednesday, 26'th Jun 2024
FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company c
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year
09:00am, Friday, 14'th Jun 2024
The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that ra
The 'Undercovered' Dozen From June 1-6
06:26pm, Friday, 07'th Jun 2024
The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Biotechs CRISPR Therapeutics, Voyager Therapeutics, and Alnylam Pharmaceuticals are covered al
Clover Health: New Business Model Is A Game Changer
07:14am, Wednesday, 05'th Jun 2024
Clover Health is making its AI-powered technology platform, Clover Assistant, available for other Medicare Advantage payors and providers under the brand name Counterpart Assistant. The new offering w
FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company co
Here's why Clover Health stock price spiked after earnings
11:54am, Wednesday, 08'th May 2024
Clover Health (NASDAQ: CLOV) stock price went parabolic on Wednesday as investors cheered the company's financial results, forward guidance, and share repurchase program. It surged by over 18%, its be
